Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Genzyme General's Seprafilm approved in Europe for cardiac surgery

Feb. 26, 1999

MS&D launches alopecia treatment in Spain

Feb. 25, 1999

New combination product represents a highly effective approach to acne vulgaris

Feb. 23, 1999

Available for licensing from VUFB: dopamine agonist for dermatology, gastrointestinal indications

Feb. 19, 1999

Early clinical results presented for ABX-IL-8 in psoriasis

Feb. 17, 1999

Fresenius will distribute Genzyme's Sepra products in select European markets

Feb. 17, 1999

Health Canada approves first active wound-healing agent

Feb. 16, 1999

AxyS initiates phase Ib studies of APC-2059 in psoriasis

Feb. 16, 1999

Human Genome Sciences initiates phase II clinical trials of new wound-healing agent

Feb. 15, 1999

Pierre Fabre Dermatologie to commercialize Allergan's Zorac in Europe

Feb. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 13, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026